全文获取类型
收费全文 | 612篇 |
免费 | 135篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 54篇 |
妇产科学 | 42篇 |
基础医学 | 85篇 |
口腔科学 | 12篇 |
临床医学 | 86篇 |
内科学 | 128篇 |
皮肤病学 | 3篇 |
神经病学 | 36篇 |
特种医学 | 82篇 |
外国民族医学 | 1篇 |
外科学 | 39篇 |
综合类 | 105篇 |
预防医学 | 26篇 |
眼科学 | 6篇 |
药学 | 29篇 |
中国医学 | 1篇 |
肿瘤学 | 39篇 |
出版年
2021年 | 4篇 |
2018年 | 11篇 |
2017年 | 9篇 |
2016年 | 12篇 |
2015年 | 14篇 |
2014年 | 13篇 |
2013年 | 27篇 |
2012年 | 14篇 |
2011年 | 15篇 |
2010年 | 18篇 |
2009年 | 14篇 |
2008年 | 16篇 |
2007年 | 41篇 |
2006年 | 29篇 |
2005年 | 27篇 |
2004年 | 19篇 |
2003年 | 15篇 |
2002年 | 10篇 |
2001年 | 22篇 |
2000年 | 16篇 |
1999年 | 13篇 |
1998年 | 18篇 |
1997年 | 35篇 |
1996年 | 27篇 |
1995年 | 9篇 |
1994年 | 16篇 |
1993年 | 12篇 |
1992年 | 11篇 |
1991年 | 12篇 |
1990年 | 14篇 |
1989年 | 18篇 |
1988年 | 22篇 |
1987年 | 15篇 |
1986年 | 12篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 15篇 |
1982年 | 6篇 |
1981年 | 16篇 |
1980年 | 16篇 |
1979年 | 39篇 |
1978年 | 17篇 |
1977年 | 6篇 |
1976年 | 12篇 |
1975年 | 5篇 |
1974年 | 6篇 |
1973年 | 7篇 |
1970年 | 5篇 |
1968年 | 6篇 |
1967年 | 5篇 |
排序方式: 共有788条查询结果,搜索用时 15 毫秒
1.
J Rochemaure P Lehert J Sauvaget M Robillard A Betbeder-Matibet 《Revue de pneumologie clinique》1988,44(1):43-47
Fifty-six patients with recurrent bronchopulmonary infections associated with chronic bronchitis were randomly allocated to 2 groups, to assess whether treatment with an immunomodulator, Diribiotin CK, could enhance resistance to infection. The double-blind, placebo-controlled prospective trial over a 9 month period showed that this immunomodulator was well tolerated and significantly reduced the rate of respiratory tract infection. The drug also significantly reduced the prescribing of antibiotic medication and the rate of absenteism from work. These effects have been demonstrated in a rigorously designed clinical study. This is the first time that a clear clinical activity has been attributed to an inducer of soluble mediators of immunity. 相似文献
2.
3.
LEE JS IM HH JUNG Y JUNG IS JANG JY CHUN YK CHO YD KIM JO CHO JY KIM YS SHIM CS & KIM BS 《Neurogastroenterology and motility》2006,18(6):493-494
Background: Recent development of extracorporeal magnetic stimulation (ECMS) which uses current‐changing magnetic fields allows the induction of electrical stimulation in the desired deep tissue. Recent study showed the sacral nerve stimulation reduces corticoanal excitability that may play a functional role in anal continence mechanisms. Preliminary study shows that ECMS of sacral nerve can modify pelvic floor function and expel rectal balloon in patients with pelvic floor dyssynergia (PFD). Aims: To evaluate the effect of ECMS compared with biofeedback therapy (BF) in patients with PFD. Methods and Materials: Thirty‐eight patients who fulfilled Rome II criteria for PFD by colon transit time and anorectal function tests, were randomly treated with 8 sessions of ECMS (2/weeks; n = 19) at prone position or BF (2/weeks; n = 19) at sitting position. Stimulation parameters were set at 50–80% of maximum intensity, 10 and 50 Hz frequency, 3 s burst length with 3 and 6 s off using arm‐typed stimulator (BioCom‐1000, Mcube Co., Korea). Symptom scores for constipation with/without anorectal function test were repeatedly measured after each treatment. Response was defined as 50% or more decreased symptom score after treatment (partial response: 30–50%, poor: <30%). Results: Fifteen patients (age 49.1 ± 13.4 years, mean ± SD; 4 men) completed 8 session of BF and 14 patients (54.5 ± 17.6 years, 3 men) completed 8 session of ECMS. Four patients of BF group discontinued treatment due to unsatisfactory therapeutic effect (n = 1) and withdrew consent (n = 3) and 5 patients of ECMS group discontinued treatment because of same reasons (n = 1, 4). Total symptom scores were significantly decreased after treatment of 8 session in both treatment groups (13.4 ± 6.6 vs. 4.3 ± 4.0 for BF, p = 0.009; 14.9 ± 5.6 vs. 3.4 ± 4.0 for ECMS, p < 0.001). Bowel movements per week were also significantly increased after treatment in both groups (median 2 vs. 7 for BF, p = 0.035; median 2 vs. 7 for ECMS, p = 0.008). Thirteen out of 15 patients showed response in BF group and 12 out of 14 showed good response in ECMS group. No adverse effects in both groups. Conclusions: ECMS is as effective as BF for the treatment of PFD. Long‐term effect of ECMS for the patients with pelvic floor dyssynergia need to be evaluated in the near future. 相似文献
4.
Hemovigilance for improvement of blood safety. 总被引:2,自引:0,他引:2
5.
6.
7.
Development of a method for direct quantification of cytomegalovirus antigenemia by flow cytometry. 总被引:5,自引:2,他引:5 下载免费PDF全文
B M Imbert-Marcille N Robillard A S Poirier M Coste-Burel D Cantarovich N Milpied S Billaudel 《Journal of clinical microbiology》1997,35(10):2665-2669
Cytomegalovirus (CMV) antigenemia was directly detected in polymorphonuclear leukocytes (PMNLs) from transplant recipients by using flow cytometry (FC). Two fixation and permeabilization methods and seven anti-CMV monoclonal antibodies (MAbs) were evaluated. 1C3, SL20, and NEA-9221 MAbs were more efficacious. The antigenemia detection threshold of FC was 0.05% positive PMNLs, and percentages correlated well with DNA viral load and the appearance of clinical symptoms. 相似文献
8.
9.
A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy 总被引:5,自引:0,他引:5
Regis Bataille Nelly Robillard Catherine Pellat-Deceunynck Martine Amiot 《Immunological reviews》2003,194(1):105-111
Summary: Multiple myeloma (MM) is a plasma cell malignancy mainly characterized by the accumulation of malignant plasma cells within the bone marrow. This review shows that the biology of CD45 illuminates that of MM and, more specifically, provides a better delineation of a tumor cell ‘hierarchy’ of clinical interest. We show that in MM, as in normal plasma cell differentiation, there is an intraclonal CD45 hierarchy that is a gradient of CD45 expression on myeloma cells directly related to their proliferation rate and differentiation status. This CD45 hierarchy allows for the design of a cellular model for MM‐cell growth and maturation in which CD45 bright myeloma cells represent the proliferating compartment and CD45 low myeloma cells the quiescent compartment. This model includes an aberrant phenotype that is annihilation rather than decline of CD45, annihilation reflecting the terminal phase of the disease and/or an aggressive presentation of MM. Data from the literature suggest that CD45 bright myeloma cells are targeted by interleukin (IL)‐6, whereas CD45 negative myeloma cells with a high clonogenic capacity are targeted by insulin/insulin‐like growth factor 1 (IGF‐1). This model will be useful for both a better understanding of the basic biology of MM and a better stratification of and therapeutic approach to the patients. Finally, this model presents MM as a self‐renewing plasma cell disease, although the first oncogenic events such as 14q32 translocations clearly occur earlier in a B cell. 相似文献
10.
A technique that allowsin vivo measurements of the specific impedance of brain structures is analysed and implemented. This technique uses the 4-electrode method. The system includes an optically isolated current source and an interchangeable electrode module. Tests on the measuring system, including the electrodes and calibration procedures, are presented. Experiments in media of known resistivity and in cat brains define the present limits of the spatial resolution. 相似文献